Impact of RADA16 Use on Outcomes Following Tonsillectomy in Children

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

134

Participants

Timeline

Start Date

December 1, 2025

Primary Completion Date

December 1, 2026

Study Completion Date

May 1, 2027

Conditions
Postoperative Pain
Interventions
DEVICE

RADA16 hydrogel

Application of 2.5% RADA16 hydrogel to the tonsillar fossae following tonsillectomy using a sterile syringe tip applicator. The gel will be spread into a thin layer within the tonsillar fossae. The gel will be left to sit for 60 seconds. A suction device will then be used to remove any excess RADA16 hydrogel, leaving a thin layer of RADA16 over the tonsillar fossae.

All Listed Sponsors
lead

Rutgers, The State University of New Jersey

OTHER

NCT07188779 - Impact of RADA16 Use on Outcomes Following Tonsillectomy in Children | Biotech Hunter | Biotech Hunter